South America - Pharmaceutical Market

The Latin America’s pharmaceutical markets will represent a value of US$80 billion at retail prices in 2013 and with their economies currently stable, their geographic location and low-cost, this continent is ideal for investors. In addition, having such a high and varied population eases recruitment for clinical trials, and the demographics show there is a very high need for pharmaceuticals.

The Argentinean pharmaceutical market is valued at US$5.6 billion in 2009. Access to medicines in the public sector has increased, particularly among the least well-off population, with initiatives such as Remediar in Argentina, PAC Saúde in Brazil, Auge in Chile, Seguro Popular in Mexico and Barrio Adentro in Venezuela. Business Monitor International expects Argentina’s pharmaceutical expenditure to grow with an annual rate of 17.8% and imports are valued at over US$10 billion.*

Register here for CPhI South America and meet leading companies from this rapidly expanding market!

* Source: Espicom Business Intelligence Ltd, Sep 2009